Expression of PGK1 by prostate cancer cells induces bone formation

Molecular Cancer Research

Volumn 7, Issue 10, 2009, Pages 1595-1604

  Jung, Younghun ^a   Shiozawa, Yusuke ^a   Wang, Jianhua ^a,c   Wang, Jingcheng ^a   Wang, Zhuo ^b   Pedersen, Elisabeth A ^a   Lee, Clara H ^a   Hall, Christopher L ^b   Hogg, Phillip J ^d   Krebsbach, Paul H ^b   Keller, Evan T ^b   Taichman, Russell S ^a  

^a UNIVERSITY OF MICHIGAN SCHOOL OF DENTISTRY   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^d UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

PHOSPHOGLYCERATE KINASE; PHOSPHOGLYCERATE KINASE 1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE MARROW CELL; CANCER CELL; CELL DIFFERENTIATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; MALE; MOUSE; NONHUMAN; OSSIFICATION; OSTEOBLAST; OSTEOCLAST; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; STROMA CELL;

ANIMALS; ANIMALS, NEWBORN; CARCINOMA; CELL DIFFERENTIATION; CELL LINE; CELL LINE, TUMOR; HUMANS; MALE; MICE; MICE, INBRED C57BL; MICE, NUDE; MICE, SCID; NEOPLASM METASTASIS; OSTEOBLASTS; OSTEOCLASTS; OSTEOGENESIS; PHENOTYPE; PHOSPHOGLYCERATE KINASE; PROSTATIC NEOPLASMS; STEM CELLS; STROMAL CELLS; TUMOR MARKERS, BIOLOGICAL;

EID: 72449204265     PISSN: 15417786     EISSN: None     Source Type: Journal    
DOI: 10.1158/1541-7786.MCR-09-0072     Document Type: Article

References (39)

1. Jacobs SC. Spread of prostatic cancer to bone. Urology 1983;21:337-344
2. Koutsilieris M, Rabbani SA, Bennett HP, Goltzman D. Characteristics of prostate-derived growth factors for cells of the osteoblast phenotype. J Clin Invest 1987;80:941-946 (Pubitemid 18075626)
3. Coleman RE, Guise TA, Lipton A, et al. Advancing treatment for metastatic bone cancer: consensus recommendations from the Second Cambridge Conference. Clin Cancer Res 2008;14:6387-6395
4. Mundy GR. Metastasis to bone: causes, consequences and therapeutic opportunities. Nat Rev Cancer 2002;2:584-593
5. Roodman GD. Mechanisms of bone metastasis. N Engl J Med 2004;350: 1655-1664
6. Taichman RS, Cooper C, Keller ET, Pienta KJ, Taichman NS, McCauley LK. Use of the stromal cell-derived factor-1/CXCR4 pathway in prostate cancer metastasis to bone. Cancer Res 2002;62:1832-1837 (Pubitemid 34408510)
7. Sun YX, Wang J, Shelburne CE, et al. Expression of CXCR4 and CXCL12 (SDF-1) in human prostate cancers (PCa) in vivo. J Cell Biochem 2003;89: 462-473 (Pubitemid 36648768)
8. Sun YX, Schneider A, Jung Y, et al. Skeletal localization and neutralization of the SDF-1(CXCL12)/CXCR4 axis blocks prostate cancer metastasis and growth in osseous sites in vivo. J Bone Miner Res 2005;20:318-329
9. Wang J, Sun Y, Song W, Nor JE, Wang CY, Taichman RS. Diverse signaling pathways through the SDF-1/CXCR4 chemokine axis in prostate cancer cell lines leads to altered patterns of cytokine secretion and angiogenesis. Cell Signal 2005; 17:1578-1592 (Pubitemid 41253997)
10. Sun YX, Fang M, Wang J, Cooper CR, Pienta KJ, Taichman RS. Expression and activation of α v β 3 integrins by SDF-1/CXC12 increases the aggressiveness of prostate cancer cells. Prostate 2007;67:61-73. (Pubitemid 46013468)
11. Wang J, Dai J, Jung Y, et al. A glycolytic mechanism regulating an angiogenic switch in prostate cancer. Cancer Res 2007;67:149-159 (Pubitemid 46142770)
12. Wang J, Shiozawa Y, Wang Y, et al. The role of CXCR7/RDC1 as a chemokine receptor for CXCL12/SDF-1 in prostate cancer. J Biol Chem 2008;283: 4283-4294
13. Migita T, Oda Y, Naito S, Morikawa W, Kuwano M, Tsuneyoshi M. The accumulation of angiostatin-like fragments in human prostate carcinoma. Clin Cancer Res 2001;7:2750-2756 (Pubitemid 32911380)
14. Daly EB, Wind T, Jiang XM, Sun L, Hogg PJ. Secretion of phosphoglycerate kinase from tumour cells is controlled by oxygen-sensing hydroxylases. Biochim Biophys Acta 2004;1691:17-22. (Pubitemid 38410946)
15. Warburg O. On the origin of cancer cells. Science 1956;123:309-314
16. Detterbeck FC, Falen S, Rivera MP, Halle JS, Socinski MA. Seeking a home for a PET, part 2: defining the appropriate place for positron emission tomography imaging in the staging of patients with suspected lung cancer. Chest 2004;125: 2300-2308 (Pubitemid 38788203)
17. Peyruchaud O, Serre CM, NicAmhlaoibh R, Fournier P, Clezardin P. Angiostatin inhibits bone metastasis formation in nude mice through a direct anti-osteoclastic activity. J Biol Chem 2003;278:45826-45832 (Pubitemid 37432728)
18. Peyruchaud O, Serre CM, NicAmhlaoibh R, Sveigaard C, Clezardin P. Does tumor angiogenesis play a role in bone metastatic process? Rev Med Suisse Romande 2004;124:83-84
19. Logothetis CJ, Lin SH. Osteoblasts in prostate cancer metastasis to bone. Nat Rev Cancer 2005;5:21-28 (Pubitemid 40052322)
20. Gerber HP, Vu TH, Ryan AM, Kowalski J, Werb Z, Ferrara N. VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation. Nat Med 1999;5:623-628 (Pubitemid 29289424)
21. Goltzman D, Bolivar I, Rabbani SA. Studies on the pathogenesis of osteoblastic metastases by prostate cancer. Adv Exp Med Biol 1992;324:165-171 (Pubitemid 23007156)
22. Shiozawa Y, Havens AM, Jung Y, et al. Annexin II/annexin II receptor axis regulates adhesion, migration, homing, and growth of prostate cancer. J Cell Biochem 2008;105:370-380
23. Balduino A, Hurtado SP, Frazao P, et al. Bone marrow subendosteal microenvironment harbours functionally distinct haemosupportive stromal cell populations. Cell Tissue Res 2005;319:255-266 (Pubitemid 40174519)
24. Cipolleschi MG, Dello Sbarba P, Olivotto M. The role of hypoxia in the maintenance of hematopoietic stem cells. Blood 1993;82:2031-2037 (Pubitemid 23293984)
25. Yin T, Li L. The stem cell niches in bone. J Clin Invest 2006;116: 1195-1201
26. Carano RA, Filvaroff EH. Angiogenesis and bone repair. Drug Discov Today 2003;8:980-989
27. Kanczler JM, Oreffo RO. Osteogenesis and angiogenesis: the potential for engineering bone. Eur Cell Mater 2008;15:100-114
28. Street J, Bao M, deGuzman L, et al. Vascular endothelial growth factor stimulates bone repair by promoting angiogenesis and bone turnover. Proc Natl Acad Sci U S A 2002;99:9656-9661
29. Honda JY, Kobayashi I, Kiyoshima T, et al. Glycolytic enzyme Pgk1 is strongly expressed in the developing tooth germ of the mouse lower first molar. Histol Histopathol 2008;23:423-432 (Pubitemid 351552327)
30. Hiraga T, Kizaka-Kondoh S, Hirota K, Hiraoka M, Yoneda T. Hypoxia and hypoxia-inducible factor-1 expression enhance osteolytic bone metastases of breast cancer. Cancer Res 2007;67:4157-4163 (Pubitemid 46815061)
31. Niida S, Kaku M, Amano H, et al. Vascular endothelial growth factor can substitute for macrophage colony-stimulating factor in the support of osteoclastic bone resorption. J Exp Med 1999;190:293-298 (Pubitemid 29354921)
32. Engsig MT, Chen QJ, Vu TH, et al. Matrix metalloproteinase 9 and vascular endothelial growth factor are essential for osteoclast recruitment into developing long bones. J Cell Biol 2000;151:879-889
33. Nakagawa M, Kaneda T, Arakawa T, et al. Vascular endothelial growth factor (VEGF) directly enhances osteoclastic bone resorption and survival of mature osteoclasts. FEBS Lett 2000;473:161-164 (Pubitemid 30254282)
34. Yang J, Fizazi K, Peleg S, et al. Prostate cancer cells induce osteoblast differentiation through a Cbfa1-dependent pathway. Cancer Res 2001;61: 5652-5659 (Pubitemid 32694953)
35. Brubaker KD, Vessella RL, Brown LG, Corey E. Prostate cancer expression of runt-domain transcription factor Runx2, a key regulator of osteoblast differentiation and function. Prostate 2003;56:13-22. (Pubitemid 36613151)
36. Hall CL, Bafico A, Dai J, Aaronson SA, Keller ET. Prostate cancer cells promote osteoblastic bone metastases through Wnts. Cancer Res 2005;65: 7554-7560 (Pubitemid 41297224)
37. Dai J, Hall CL, Escara-Wilke J, Mizokami A, Keller JM, Keller ET. Prostate cancer induces bone metastasis through Wnt-induced bone morphogenetic protein-dependent and independent mechanisms. Cancer Res 2008;68: 5785-5794
38. Wu TT, Sikes RA, Cui Q, et al. Establishing human prostate cancer cell xenografts in bone: induction of osteoblastic reaction by prostate-specific antigen-producing tumors in athymic and SCID/bg mice using LNCaP and lineage-derived metastatic sublines. Int J Cancer 1998;77:887-894 (Pubitemid 28378138)
39. Lay AJ, Jiang XM, Kisker O, et al. Phosphoglycerate kinase acts in tumour angiogenesis as a disulphide reductase. Nature 2000;408:869-873 (Pubitemid 32016098)